Show simple item record

Feasibility of desensitizing children highly allergic to peanut by high-dose oral immunotherapy

dc.contributor.authorReier-Nilsen, Tonje
dc.contributor.authorMichelsen, Merethe Melbye
dc.contributor.authorCarlsen, Karin C. Lødrup
dc.contributor.authorCarlsen, Kai-Håkon
dc.contributor.authorMowinckel, Petter
dc.contributor.authorNygaard, Unni Cecilie
dc.contributor.authorNamork, Ellen
dc.contributor.authorBorres, Magnus P
dc.contributor.authorHåland, Geir
dc.date.accessioned2022-07-25T13:08:19Z
dc.date.available2022-07-25T13:08:19Z
dc.date.created2018-10-02T13:20:37Z
dc.date.issued2018
dc.identifier.citationAllergy. European Journal of Allergy and Clinical Immunology. 2018, 74 (2), 337-348.
dc.identifier.issn0105-4538
dc.identifier.urihttps://hdl.handle.net/11250/3008242
dc.language.isoeng
dc.titleFeasibility of desensitizing children highly allergic to peanut by high-dose oral immunotherapy
dc.typePeer reviewed
dc.typeJournal article
dc.description.versionpublishedVersion
dc.source.pagenumber337-348
dc.source.volume74
dc.source.journalAllergy. European Journal of Allergy and Clinical Immunology
dc.source.issue2
dc.identifier.doi10.1111/all.13604
dc.identifier.cristin1617175
cristin.unitcode7502,4,3,0
cristin.unitnameAvdeling for toksikologi og risiko
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Files in this item

Thumbnail
Name:
Feasibility+Reier-Nilsen_et_al ...
Size:
691.6Kb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record